COBALT XT ICDs and CRT-Ds
Cobalt™ XT ICDs and CRT-Ds are enabled with BlueSync™ technology, allowing for tablet-based programming and app-based remote monitoring. These devices include an automated ATP algorithm and are compatible with a simplified heart failure risk stratification tool.
Download Brochure
Overview
the Future IS HERE
Meet Cobalt XT ICDs and CRT-Ds
Exclusive ATP algorithm, heart failure risk stratification, tablet-based programming and app-based remote monitoring, extended longevity, and 40 J on all shocks.
UNMATCHED FEATURE SUITE
Extended Longevity
Real-world projections based on CareLink™ patient data.
Increased Energy Delivery
MAXIMUM PROGRAMMED ENERGY 40 J
MAXIMUM DELIVERED ENERGY† 47 J
MAXIMUM STORED ENERGY‡ 47 J
Intrinsic ATP
Intrinsic ATP™ is the only automated and smart ventricular antitachycardia pacing (ATP) algorithm that provides individualized therapy in real time.
In a virtual modeling study, Intrinsic ATP’s termination rate was 22% higher than traditional ATP (burst) with no difference in acceleration rate.7
% of termination
Simplified Programming
On/Off
INDIVIDUALIZED Therapy
ATP designed
for each VT
Real-time Response
If VT is redetected,
iATP automatically
adjusts the next
ATP sequence
REIMAGINED CONNECTIVITY
BlueSync technology within Cobalt XT enables secure, wireless communication.
Tablet-based CareLink SmartSync™ device manager
Cobalt XT ICDs and CRT-Ds
MyCareLink Heart™ mobile app or MyCareLink Relay™ Home Communicator
CareLink network and the BeConnected service
STREAMLINED WORKFLOWS & HEART FAILURE MANAGEMENT
TriageHF™|| is a simplified, integrated heart failure risk assessment tool that alerts clinicians to clinically relevant changes in a patient’s status that may lead to a heart failure decompensation.
Patient’s risk level is
generated by assessing8:
- OptiVol™
- Patient Activity
- AT/AF Burden
- Ventricular Rate during AT/AF
- % Ventricular Pacing
- Shocks
- Treated VT/VF
- Night Ventricular Rate
- Heart Rate Variability
Risk score
Risk of a HF hospitalization in the next 30 days9
HIGHHazard Ratio 10x
MEDIUMHazard Ratio 2.1x
LOWNeg Pred Value 99.4%
System features & Exclusive Algorithms
Discover exclusive features and algorithms available in Cobalt XT ICDs and CRT-Ds.
Additional resources
Related Pages
Medtronic 24-hour support
Medtronic Academy
Find additional feature information along with a variety of educational resources and tools.
Visit Medtronic Academy
*
With AdaptivCRT™ programmed to BiV and LV.
†
Energy delivered at connector block into a 50 Ω ± 1% load.
‡
Energy stored at charge end on capacitor.
§
From ADVANCE III, using ATP during charging along with NID = 30/40 programming, ATP reduced shocked episodes by 52%.10
||
TriageHF is not an alarm. The TriageHF assessment does not replace heart failure assessments in standard clinical practice. Medical treatment should not be modified remotely based solely on the TriageHF assessment. Interpretation of the TriageHF assessment requires clinical judgement by a medical professional. The TriageHF assessment should be used in conjunction with professional guidelines for patient management decisions.
References
1
Medtronic Claria MRI™ Quad CRT-D SureScan™ and Amplia MRI™ Quad CRT-D SureScan™ Median Projected Service Life based on U.S. CareLink™ transmission data as of January 2019; UC201600236 EN.
2
Medtronic Cobalt™ XT HF Quad MRI SureScan™ Model DTPA2QQ device manual.
3
Medtronic Evera MRI™ XT DR SureScan™ and Evera MRI™ S DR SureScan™ Median Projected Service Life based on U.S. CareLink™ transmission data as of January 2019; UC201600236 EN.
4
Medtronic Cobalt™ XT DR MRI SureScan™ Model DDPC3D4 device manual.
5
Medtronic Visia AF™ VR and Visia AF MRI™ VR SureScan™ Median Projected Service Life based on U.S. CareLink™ transmission data as of January 2019; UC201600236 EN.
6
Medtronic Cobalt™ XT VR MRI SureScan™ Model DVPC3D4 device manual
7
Swenson D, et al. A self-adaptive approach to antitachycardia pacing – a head to head comparison using advanced computational modeling. Poster P6555 presented at ESC Congress 2019; Amsterdam.
8
Medtronic CareLink™ Heart Failure Risk Status Technical Manual M945636A001 A.
9
Cowie MR, Sarkar S, Koehler J, et al. Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting. Eur Heart J. August 2013;34(31):2472-2480.
10
Arenal A, Proclemer A, Kloppe A, et al. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial. Europace. November 2016;18(11):1719-1725.